Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Medullary 9 Lung Neoplasms 8 Thyroid Neoplasms 7 Neoplasms 5 Neoplasm Metastasis 5 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Stomach Neoplasms 2 Pleural Effusion 2 Kidney Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

Everolimus 16 Octreotide 6 pembrolizumab 5 lanreotide 5 Sunitinib 5 Magnetic Resonance Spectroscopy 5 gallium Ga 68 dotatate 4 cabozantinib 4 Nivolumab 4 Carboplatin 4 telotristat ethyl 3 lenvatinib 3 arginyllysine 3 Specimen Handling 3 Etoposide 3 Erlotinib Hydrochloride 3 Bevacizumab 3 surufatinib 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 amino-acid, glucose, and electrolyte solution 2 X-Rays 2 Temozolomide 2 Sorafenib 2 Phantoms, Imaging 2 Paclitaxel 2 Oxaliplatin 2 Ipilimumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡